Myocardial Inflammation at FDG PET/MRI and Clinical Outcomes in Symptomatic and Asymptomatic Participants after COVID-19 Vaccination
暂无分享,去创建一个
J. Fish | R. Wald | A. Cheung | P. Thavendiranathan | C. Marschner | S. Epelman | K. Hanneman | D. Gustafson | H. Abdel-Qadir | Jason E. Fish | R. Iwanochko | K. Howe | Rachel Hong
[1] Xia Li,et al. Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis , 2022, Journal of the American College of Cardiology.
[2] S. Zimmer,et al. Cardiac magnetic resonance follow-up of COVID-19 vaccine associated acute myocarditis , 2022, Frontiers in Cardiovascular Medicine.
[3] P. Thavendiranathan,et al. Thoracic and Cardiac Imaging / Imagerie cardiaque et imagerie thoracique , 2022 .
[4] B. Wintersperger,et al. Clinical Impact of Cardiac MRI T1 and T2 Parametric Mapping in Patients with Suspected Cardiomyopathy. , 2022, Radiology.
[5] P. Veit-Haibach,et al. Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis. , 2022, Radiology.
[6] R. Wald,et al. Cardiac MRI and Clinical Follow-up in COVID-19 Vaccine–associated Myocarditis , 2022, Radiology.
[7] R. Wald,et al. Myocarditis Following COVID-19 Vaccination , 2022, Cardiology Clinics.
[8] B. Tai,et al. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis , 2022, The Lancet Respiratory Medicine.
[9] J. Cavalcante,et al. Cardiac Magnetic Resonance Imaging Midterm Follow Up of COVID-19 Vaccine–Associated Myocarditis , 2022, JACC: Cardiovascular Imaging.
[10] R. Wald,et al. Myocardial Injury Pattern at MRI in COVID-19 Vaccine–Associated Myocarditis , 2022, Radiology.
[11] Michael John Smith,et al. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. , 2022, JAMA.
[12] J. Fish,et al. Combined Cardiac Fluorodeoxyglucose-Positron Emission Tomography/Magnetic Resonance Imaging Assessment of Myocardial Injury in Patients Who Recently Recovered From COVID-19. , 2022, JAMA cardiology.
[13] P. Veit-Haibach,et al. Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis , 2021, European Journal of Hybrid Imaging.
[14] J. Udell,et al. Cardiac MRI Assessment of Nonischemic Myocardial Inflammation: State of the Art Review and Update on Myocarditis Associated with COVID-19 Vaccination , 2021, Radiology. Cardiothoracic imaging.
[15] T. Grist,et al. Myocarditis Associated with mRNA COVID-19 Vaccination , 2021, Radiology.
[16] P. Hotez,et al. Myocarditis With COVID-19 mRNA Vaccines , 2021, Circulation.
[17] J. Gargano,et al. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021 , 2021, MMWR. Morbidity and mortality weekly report.
[18] E. Nagel,et al. Standardized image interpretation and post-processing in cardiovascular magnetic resonance - 2020 update , 2020, Journal of Cardiovascular Magnetic Resonance.
[19] B. Wintersperger,et al. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy , 2019, Journal of Cardiovascular Magnetic Resonance.
[20] Matthias Gutberlet,et al. Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations. , 2018, Journal of the American College of Cardiology.
[21] R. Wald,et al. Noninvasive hematocrit assessment for cardiovascular magnetic resonance extracellular volume quantification using a point-of-care device and synthetic derivation , 2018, Journal of Cardiovascular Magnetic Resonance.
[22] R. Blankstein,et al. Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients With Suspected Myocarditis. , 2017, Journal of the American College of Cardiology.
[23] R. Herfkens,et al. Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis , 2017, Clinical nuclear medicine.
[24] J. Francis. Vaccine Associated Myocarditis , 2017 .
[25] P. Heusch,et al. Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI , 2018, Journal of Nuclear Cardiology.
[26] E. Miller,et al. Quantitative interpretation of FDG PET/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis , 2014, Journal of Nuclear Cardiology.
[27] N. Funabashi,et al. Determination of optimum periods between onset of suspected acute myocarditis and ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium. , 2013, International journal of cardiology.
[28] Tiina Heliö,et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2013, European heart journal.
[29] MinJae Lee,et al. Multiple imputation for left‐censored biomarker data based on Gibbs sampling method , 2012, Statistics in medicine.
[30] Aki Tsuchiya,et al. Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies , 2012, PloS one.
[31] H. Ohira,et al. 18F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[32] G. Kolodny,et al. Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet. , 2008, AJR. American journal of roentgenology.
[33] T. Yokoyama,et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[35] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.